Stockscreener 앱 받기
0.00
100.00%
-0.065
시간 외 거래:
.14
0.14
+
전일 마감가:
$0.065
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$288.80K
수익:
-
순이익/손실:
$-19.93M
주가수익비율:
0.00
EPS:
-9.75
순현금흐름:
$-14.82M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$3.23
Tff Pharmaceuticals Inc Stock (TFFP) Company Profile
명칭
Tff Pharmaceuticals Inc
전화
737-802-1973
주소
2600 VIA FORTUNA, SUITE 360, AUSTIN
TFFP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TFFP
Tff Pharmaceuticals Inc
|
0.00 | 288.80K | 0 | -19.93M | -14.82M | -9.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Tff Pharmaceuticals Inc Stock (TFFP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-05-19 | 재개 | H.C. Wainwright | Buy |
| 2021-02-08 | 개시 | H.C. Wainwright | Buy |
| 2020-12-07 | 개시 | B. Riley Securities | Buy |
| 2020-08-17 | 재확인 | Maxim Group | Buy |
| 2020-07-08 | 개시 | Maxim Group | Buy |
Tff Pharmaceuticals Inc 주식(TFFP)의 최신 뉴스
Airbus Stays Steady Despite Tariff Troubles, TF1 And TP Show Mixed Signals - Finimize
Aspergillosis Market Expected to Rise by 2034, Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, - Barchart.com
Eastman Chemical's Earnings Surpass Estimates, Sales Miss in Q1 - The Globe and Mail
LKQ (LKQ) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Head-To-Head Contrast: NeuroSense Therapeutics (NASDAQ:NRSN) versus TFF Pharmaceuticals (NASDAQ:TFFP) - Defense World
Northrop Grumman (NOC) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Aspergillosis Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail
Aspergillosis Market on Track for Major Expansion by 2034, - openPR.com
Aspergillosis Market on Track for Major Expansion by 2034, According to DelveInsight | F2G, Pulmatrix, TFF Pharmaceuticals, Scynexis, Pulmocide - The Globe and Mail
If You Had Invested $1,000 in ServiceNow Stock 10 Years Ago, Here's How Much You Would Have Today - The Globe and Mail
TFF Pharmaceuticals approves dissolution plan By Investing.com - Investing.com South Africa
TFF Pharmaceuticals approves dissolution plan - Investing.com India
Tff Pharmaceuticals Inc to Host Earnings Call - ACCESS Newswire
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends - The Globe and Mail
Pre-market Movers: PALI, KROS, AVGR, TRVI... - RTTNews
TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration - Yahoo Finance
TFF Pharmaceuticals to Exit Nasdaq: Complete Liquidation Plan Leaves Shareholders in Limbo - Stock Titan
Updated Zoetis label for Librela ‘a relief,’ says Piper Sandler - MSN
Tonix Pharmaceuticals promotes Fogarty to CTO - MSN
TFF Pharmaceuticals authorizes special share issuance By Investing.com - Investing.com Canada
TFF Pharmaceuticals authorizes special share issuance - MSN
TDG Gold upsizes non-brokered private placement - MSN
Larimar started at buy by Truist on Friedreich's ataxia drug - MSN
Inhalable Drugs Market Poised for Strong Growth: Unpacking the Emerging Trends, Key Players and Market Forecasts - openPR
Takeda-backed Ascentage Pharma prices $126M U.S. IPO - MSN
Lung Transplant Rejection Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | Kamada, Genentech, Bristol Myers Squibb, MimeTech, Corline Biomedical - Barchart
Lung Transplant Rejection Pipeline 2024: In-depth Clinical - openPR
Aspergillosis Market Expected to rise, 2034 | Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, I - The Globe and Mail
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.70% - MSN
UBI Pharma Inc. - Contract Pharma
Thin Film Drug Manufacturing Market in 2024: Thin Film Drug Innovations Enhance Compliance And Effectiveness - EIN News
McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales - MSN
United States shares lower at close of trade; Dow Jones Industrial Average down 0.53% - Investing.com India
TFFP Stock Plummets to 52-Week Low of $0.21 Amid Market Struggles - Investing.com Australia
Nasdaq Down 50 Points; US Initial Jobless Claims Rise - Benzinga
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket - Benzinga
TFFP Stock Plummets to 52-Week Low of $0.21 Amid Market Struggles By Investing.com - Investing.com South Africa
Crude Oil Jumps 2%; Macy's Lowers Earnings Forecast - Benzinga
U.S. STOCKS Candel Therapeutics, Broadcom, Reddit - XM
Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations - Benzinga
Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
TFF Pharmaceuticals to be delisted from Nasdaq - Investing.com
TFF Pharmaceuticals to be delisted from Nasdaq By Investing.com - Investing.com Nigeria
Selling Your Tff Pharmaceuticals Inc (NASDAQ: TFFP) Stock? Here’s What You Need To Know - Stocks Register
What You Didn’t Know About WW International Inc (NASDAQ: WW) This Week - Stocks Register
United States shares lower at close of trade; Dow Jones Industrial Average down 0.70% - MSN
TFF Pharmaceuticals IncOrdinary Shares (TFFP) reports earnings - Quartz
TFF Pharmaceuticals, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
TFF Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.70% - MSN
TFF Pharmaceuticals, Inc. Announces Chief Executive Officer Changes - Marketscreener.com
Tff Pharmaceuticals Inc (TFFP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):